Welcome to our new PFMs!

The number of APC Pharmacy-Facility Members continues to grow.

FAQs and other new-chapter resources from USP

APC leaders met this week with USP staff for a touch-base. One outcome of that meeting is the need to spread the word about several USP compounding resources.

Court publishes dismissal in Novo case against Brooksville

In a ruling published this week, the U.S. District Court for the Middle District of Florida, Tampa Division, granted a motion to dismiss in the case of Novo Nordisk, Inc. v. Brooksville Pharmaceuticals.

Bad journalism, ketamine studies, and scammers

I don’t have a clever theme to unite the three things I want to share this week, so I’ll just dive in...

APC members honored by PCCA

Updated PCAB standards available

PCAB announced this week that updated PCAB Accreditation Standards are now available to download.

Meet your 2024 Board of Directors

In elections that closed last week, the APC membership elected (or re-elected) five board members.

Perplexed by new USP standards?

We’ve got resources for you!

What do BOPs think about compounding?

This week APC sent a 15-question survey to members and directors of state boards of pharmacy to gauge their views on the regulation of pharmacy compounding in their state.

A procedural pathway to Category 1

The addition by FDA of several peptides to Category 2 on September 29 officially placed them out of reach for compounding, at least for the time being.

Medisca is APC’s first $100k Patron

Pharma Source Direct bumps up its support for 2024, too.

Mark your calendar (doggone it!)

2024 is coming fast, and before you know, your calendar will fill up.

APC requests transparency on new Cat 2 substances

In a letter this week to Gail Bormel, director of FDA’s Office of Compounding Quality and Compliance, APC called for transparency regarding the recent addition of substances to Category 2.

A righteous rant

When it comes to tutoring reporters about pharmacy compounding in the media, I feel sometimes like I’m in one of those old Tom & Jerry cartoons.

Pharmacy Compounding Foundation offers technician grants

The Pharmacy Compounding Foundation will be offering up to ten (10) pharmacy technicians a grant valued at up to $495 to attend the APC, PCF, VCU online 15-hour curriculum.

Draft GFI on ophthalmics, final GFI on alcohol testing issued

FDA has released two new guidance documents this month that APC members will want to familiarize themselves with.

VIDEO BRIEFING: Reduce your credit card swipe fees

Missed our briefing a couple of weeks ago about APC’s new group purchasing agreement with WorldPay?

Another APC member takes helm at NCPA

Plus: Letendre honored and APC represents at recent convention

Shortage drug compounding ads reach 800k+ during CCH

It’s called geofencing — the ability to target digital messaging to individuals who meet a defined demographic criteria within a defined geographic area.

It’s the 4th quarter. Can we come from behind?

It’s the 4th quarter. Can we come from behind? It’s the start of the fourth quarter and we’re behind — and I’m not talking about a football game.

Semaglutide statement and peptide brief updated

In light of recent developments, we’ve updated our official statement on shortage drug compounding and semaglutide, as well as our Prescriber Brief on peptide compounding.

Judge throws out one Novo lawsuit

Last week, a Florida District Court judge dismissed Novo Nordisk’s lawsuit against Brooksville Pharmacy, one of the four APC members the drugmaker sued back in June over semaglutide compounding in shortage.

New PFM benefit: Best pricing from Capital Drug

APC has leveraged the strength of our large number of Pharmacy-Facility Members to strike a deal with Capital Drug on finished-form drugs.

FDA warns on compounded ketamine, lack of monitoring

FDA this week issued a statement warning of potential risks associated with compounded ketamine, including oral formulations, for treatment of psychiatric disorders.

Keeping prescribers in the know

The providers you work with may be smart cookies, but they don’t always know compounding. Providers need to know about those issues, and it’s up to you to keep them informed.

Time to vote in APC Board elections

Voting is now open for seats on the 2024 APC Board of Directors.

Big thanks to CompPAC investors

CompPAC is the way APC supports members of Congress who think like you do about pharmacy compounding. And where does CompPAC get its funding? From compounders like you.

Licensed in California? You’ll want to see this

APC staff has prepared a comparison document illuminating the differences between the new USP Chapter <797> on sterile compounding that takes effect November 1 and proposed regulation from the California Board of Pharmacy.

Senators to FDA: Preserve access to cBHT

Five U.S. Senators have written to the FDA urging that the agency assure continued patient access to compounded hormones for patients.

FDA puts some peptides off-limits

Last Friday, the FDA announced that it has updated the list of bulk drug substances nominated for use under section 503A.